Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With a Single Brain Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05018702
What this trial is testing

ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases

Who this might be right for
HER2-positive, Metastatic Breast Cancer
Fudan University 32
Not applicableNot Yet RecruitingNCT06611306
What this trial is testing

BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.

Who this might be right for
Brain Metastases, AdultBreast Cancer
Imperial College London 42
Not applicableStudy completedNCT06690411
What this trial is testing

Comparison of Myofascial Release and Mulligan Concept Techniques in Patients With Cervicogenic Headache

Who this might be right for
Cervicogenic HeadacheCervicogenic Headaches
Istanbul Medipol University Hospital 40
Large-scale testing (Phase 3)UnknownNCT02338011
What this trial is testing

Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)

Who this might be right for
Non-Small Cell Lung CancerBrain MetastasesEGFR Gene Mutation
Shanghai Chest Hospital 210
Testing effectiveness (Phase 2)Study completedNCT01516983
What this trial is testing

Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

Who this might be right for
Non-small Cell Lung CancerBrain Metastases
Betta Pharmaceuticals Co., Ltd. 15
Testing effectiveness (Phase 2)Looking for participantsNCT03340129
What this trial is testing

Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

Who this might be right for
Melanoma Stage Iv
Melanoma Institute Australia 218
Large-scale testing (Phase 3)Ended earlyNCT04395339
What this trial is testing

GM1 Prophylaxis for WBRT Related Cognitive Dysfunction

Who this might be right for
Brain MetastasesRadiotherapy Side EffectCognitive Impairment+2 more
Sun Yat-sen University 51
Testing effectiveness (Phase 2)Looking for participantsNCT07402343
What this trial is testing

Tarlatamab for SCLC Brain Metastases

Who this might be right for
Small Cell Lung CancerBrain Metastases, Adult
Maastricht University Medical Center 35
Testing effectiveness (Phase 2)Ended earlyNCT00476827
What this trial is testing

A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain

Who this might be right for
Breast Cancer
Duke University 16
Testing effectiveness (Phase 2)UnknownNCT04639271
What this trial is testing

Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Shandong Cancer Hospital and Institute 100
Testing effectiveness (Phase 2)Study completedNCT00006259
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Cancer
Case Comprehensive Cancer Center 10
Early research (Phase 1)Study completedNCT00929903
What this trial is testing

Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment

Who this might be right for
Childhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal TumorChildhood Central Nervous System Germ Cell Tumor+10 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)UnknownNCT03933982
What this trial is testing

Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast CancerBrain Metastases
Chinese Academy of Medical Sciences 30
Large-scale testing (Phase 3)Ended earlyNCT00096265
What this trial is testing

Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
National Cancer Institute (NCI) 126
Testing effectiveness (Phase 2)Looking for participantsNCT07304739
What this trial is testing

Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07454707
What this trial is testing

Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial

Who this might be right for
Stroke, Ischemic
Sunnybrook Health Sciences Centre 1,204
Testing effectiveness (Phase 2)UnknownNCT02655536
What this trial is testing

Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial

Who this might be right for
Carcinoma, Non-Small-Cell LungBrain Neoplasms
National Taiwan University Hospital 109
Testing effectiveness (Phase 2)Ended earlyNCT00872482
What this trial is testing

Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases

Who this might be right for
Metastatic Non-Small Cell Lung Cancer
YM BioSciences 21
Large-scale testing (Phase 3)UnknownNCT04058704
What this trial is testing

Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Betta Pharmaceuticals Co., Ltd. 296
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Next Page